ADDvise - M&A Fueled Growth Ahead
2022-03-14 09:45:00
Redeye retains its Base Case and long-term forecasts following a mixed Q4 report with strong sales and soft margins. Management expects efficiency measures to gradually improve margins in 2022, a year where ADDvise most likely will experience significant sales growth driven by M&A.
Read more and download the Research Update.
Follow companies at Redeye to receive the latest equity research within Life Science and Technology.
This is a press release from Redeye - Research Powered Investment Banking. www.redeye.se/